Safety and immunogenicity of an adjuvant-free peptide vaccine targeting IL-17A: Phase 1 randomized controlled trial. (linkinghub.elsevier.com)

Authors: Kasahara S … Tomita T Journal: iScience Published: 2026-07-21 DOI: https://doi.org/10.1016/j.isci.2026.116817